FRANCO, Luigina
 Distribuzione geografica
Continente #
NA - Nord America 4.658
EU - Europa 3.584
AS - Asia 2.622
SA - Sud America 298
Continente sconosciuto - Info sul continente non disponibili 45
AF - Africa 44
OC - Oceania 5
Totale 11.256
Nazione #
US - Stati Uniti d'America 4.535
SG - Singapore 1.088
RU - Federazione Russa 1.083
GB - Regno Unito 981
CN - Cina 911
IT - Italia 345
SE - Svezia 283
BR - Brasile 241
FR - Francia 211
HK - Hong Kong 198
IE - Irlanda 193
FI - Finlandia 184
VN - Vietnam 169
DE - Germania 159
KR - Corea 82
CA - Canada 69
UA - Ucraina 54
IN - India 30
BD - Bangladesh 29
AR - Argentina 21
NL - Olanda 21
IL - Israele 17
JP - Giappone 17
PL - Polonia 17
TR - Turchia 15
ID - Indonesia 14
BE - Belgio 13
ZA - Sudafrica 13
MX - Messico 12
CR - Costa Rica 11
EC - Ecuador 11
HN - Honduras 10
IQ - Iraq 10
PK - Pakistan 10
ES - Italia 8
CO - Colombia 7
NG - Nigeria 7
CW - ???statistics.table.value.countryCode.CW??? 6
KE - Kenya 6
SA - Arabia Saudita 6
SC - Seychelles 6
AU - Australia 5
GT - Guatemala 5
PY - Paraguay 5
CL - Cile 4
GR - Grecia 4
IR - Iran 4
PT - Portogallo 4
BG - Bulgaria 3
BO - Bolivia 3
CH - Svizzera 3
JM - Giamaica 3
LB - Libano 3
MG - Madagascar 3
NI - Nicaragua 3
NP - Nepal 3
PH - Filippine 3
RS - Serbia 3
SV - El Salvador 3
UZ - Uzbekistan 3
VE - Venezuela 3
BJ - Benin 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EE - Estonia 2
ET - Etiopia 2
GP - Guadalupe 2
LT - Lituania 2
MA - Marocco 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
RO - Romania 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AT - Austria 1
AZ - Azerbaigian 1
BS - Bahamas 1
DK - Danimarca 1
EU - Europa 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
QA - Qatar 1
TN - Tunisia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.219
Città #
Southend 843
Jacksonville 605
Ashburn 600
Singapore 591
Chandler 415
San Jose 355
Woodbridge 330
Moscow 312
Hong Kong 196
Dallas 193
Dublin 192
Ann Arbor 183
Council Bluffs 166
Houston 163
New York 134
Verona 127
Beijing 93
Lawrence 72
Princeton 72
The Dalles 71
Jinan 68
Nanjing 66
Wilmington 66
Ho Chi Minh City 60
Shenyang 58
Los Angeles 52
Hanoi 48
Tianjin 45
Hebei 42
São Paulo 41
Changsha 36
Zhengzhou 35
Buffalo 34
Santa Clara 33
Haikou 32
Munich 31
Helsinki 29
Hangzhou 28
Nanchang 28
Ningbo 27
Lancaster 24
Milan 23
Taiyuan 23
Sindelfingen 22
Boardman 18
Guangzhou 18
Jiaxing 17
Las Vegas 17
Taizhou 17
Providence 16
Tokyo 16
Toronto 16
Fuzhou 15
Orem 14
Rome 14
Brussels 13
Montreal 13
Annandale 12
Atlanta 12
Columbus 12
Johannesburg 12
Redondo Beach 12
San Francisco 12
London 11
Naples 11
Venice 11
Chicago 10
Frankfurt am Main 10
Lanzhou 10
Rio de Janeiro 10
Seoul 10
Norwalk 9
Turku 9
Brooklyn 8
Fairfield 8
Mumbai 8
Philadelphia 8
Phoenix 8
San José 8
Boston 7
Chennai 7
Da Nang 7
Radomsko 7
Warsaw 7
Abuja 6
Auburn Hills 6
Curitiba 6
Denver 6
Detroit 6
Düsseldorf 6
Haiphong 6
Jakarta 6
Nairobi 6
Washington 6
Willemstad 6
Amsterdam 5
Barnet 5
City of London 5
Guatemala City 5
Paris 5
Totale 7.215
Nome #
Piperacillin-Tazobactam penetration into human pancreatic juice 247
Copper and zinc status during acute inflammation: studies on blood, liver and kidneys metal levels in normal and inflamed rats 240
Adenocarcinoma pancreatico umano primario ed espressione dell’ossido nitrico sintetasi inducibile e cicloossigenasi–2. 235
Expression of inducible nitric oxide synthase and cyclooxygenase-2 in human pancreas 228
Anti-inflammatory properties of superoxide dismutase derivatives (SOD-PEG-3 and 18) in carrageenan pleurisy 223
Farmacocinetica e farmacodinamica di piperacillina–tazobactam in pazienti con fistola pancreatica esterna 222
Anti-Inflammatory activity of superoxide dismutase derivatives 221
Copper and Inflammation: a rationale for a different anti-inflammatory therapy 218
Synthesis and anti-inflammatory effects of some bis(2-benzimidazolyl)thioethers and theri copper(II) chelates, orally administered to rats 210
Copper and acute inflammation 208
Diffusibilità di cefuroxim e cefoxitina in essudati pleurici ottenuti sperimentalmente nel ratto (pleurite da carragenina e da Bordetella pertussis). 205
40% but not 20% ethanol is an irritant able to evoke gastric release of PGE2 in man 204
Effect of acute alcohol administration on gastric prostaglandin (PGE2) in healthy controls (C) and in chronic alcoholics (CA). 203
Copper and its role in the modulation of the inflammatory process as a new approch to the anti-arthritic therapy 198
The acute inflammatory process in copper-deprived rats 196
Copper metabolism in acute inflammatory process and its possible significance for a novel approch to the therapy of inflammation 193
Anti-ulcer activity of carbenoxolone and ISF 3401 on PGE2 release in rat gastric mucosa. 190
Effect of acute exercise on plasma nitric oxide level in human 190
Gastric and systemic effects of carbenoxolone and its derivative ISF 2715 in humans 187
Concerning the role of endogenous copper in the acute inflammatory process 187
Riduzione della componente essudativa e cellulare in pleuriti sperimentali e con "coverslip" in seguito a trattamento con calcitonina 180
Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic cancer 178
Serum Copper concentration and ceruloplasmin activity during carrageenan foot oedema in rat 178
Expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic cancer. 170
Theophylline inhibition of BCG-induced pulmonary inflammatory responses 168
Copper complex in the treatment of experimental ulcers 166
Interleuchina –4 e ossido nitrico nella pancreatite cronica umana. 165
Comportamento in vitro di leucociti e macrofagi trattati con calcitonina pura: valutazione della risposta metabolica alla fagocitosi attraverso glucosio 1-14C. 164
Essudati pleurici e attività antibatterica del cefuroxim: azione in vivo e vitro 162
Anti-ulcer activities of copper in the rat 162
Cross-Talk between Inducible Nitric Oxide Synthase and Cyclooxygenase in Helicobacter-pylori-induced gastritis 159
Farmacovigilanza: esperienza pilota di monitoraggio intensivo ospedaliero 158
Anti-ulcer activities of copper in the rat 156
Essudati pleurici e attività antibatterica del cefuroxim: azione in vivo e in vitro. 152
Effect of Sulglycotide on PGE2 and gastric mucus in healthy volunteers 149
Theophylline inhibition of BCG-induced pulmonary inflammatory responses. 147
Effect of calcitonin on different inflammatory models 145
Effects of NSAIDs on liver microsomal mono-oxygenase system and products of oxidative metabolism of arachidonic acid. 145
Effect of exercise on plasma nitric oxide level in men 145
Role of nitric oxide in prevention of ethanol-induced gastric damage by CuNSN a copper-chelating compound 142
Effetto della somministrazione acuta di alcool sul rilascio di prostaglandine E2 gastriche. Studio nei volontari sani e negli etilisti cronici 142
Prostaglandins and nitric oxide in copper-complex mediated protection against ethanol-induced gastric damage 142
Nitric oxide enhances prostaglandin production in ethanol-induced gastric mucosal injury in rats 140
Increased expression of i-NOS and COX-2 in human antrum with Helicobacter pylori 139
Gastric and systemic effects of carbenoxolone and its derivative ISF 2715 137
Essudati pleurici e attivita' antibatterica del cefuroxim: azione in vivo e in vitro. 136
Toxicological investigations and pharmacological studies of a new arylacetc anti-inflammatory compound 132
Effetti della calcitonina su alcuni modelli di infiammazione sperimentale 132
Role of nitric oxide and prostaglandin E2 in gastroprotection induced by lipopolysaccharide in ethanol-mediated damage in rats 131
Measuring gastric PGE2 release in healthy and alcoholic subjects after ethanol stimulation 130
The effect of NS-398, a selective cyclooxygenase-2 inhibitor, in human gastric mucosa biopsy during H. Pylori infection 129
The role of copper in preventing gastric damage by acetylsalicylic acide 127
Role of inducible nitric oxyde synthase and cyclooxygenase-2 in human pancreatic adenocarcinoma 127
Piperacillin - Tazobactam penetration into human pancreatic juice 126
Prevention of ethanol-induced damages by copper-chelating drugs: involvement of nitric oxide 124
Effect of ethanol on eicosanoid synthesis by healthy volunteers and chronic alcoholics gastric mucosal pieces 124
Relationship between hepatic inhibition of cyclo-oxygenase by non steroidal anti-inflammatory drugs and changes on cytochrome P-450 monooxygenase system 122
Penetration of piperacillin–tazobactam into human pancreatic juice 119
Role of nitric oxide in gastroprotection induced by copper-chelating drugs 118
Role of NO and PG in gastroprotection induced by lipopolysaccharide in rats 117
Copper derivatives and gastroprotection 115
Piperacillin-Tazobactam penetration in pacreatic juice 114
Study on cross talk between inducible nitric-oxide synthase and cyclooxygenase in human gastric mucosa biopsy during Helicobacter pylori infection 112
NO in Cu(II)(L-Trp)(L-Phe)-induced gastroprotection- 112
Release of eicosanoid by rat gastric mucosa and its pharmacological modification 110
On effects of calcitonin on the immobilization induced state of atrophy in the growth cartilage of rats 109
NS-398, a selective cyclooxygenase-2 inhibitor, in human gastric mucosa biopsy 108
Meccanismi che determinano la tossicità da FANS a livello gastrointestinale 105
Regulation of gastric mucosal integrity by endogenous nitric oxide 104
Effect of copper on gastric eicosanoid production 97
Prevention of ethanol-induced damages by copper-chelating drugs: involvement of nitric oxide 92
The role of copper in preventing gastric damage by acetylsalicylic acid 88
Totale 11.256
Categoria #
all - tutte 35.152
article - articoli 14.559
book - libri 878
conference - conferenze 17.218
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.497
Totale 70.304


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022273 0 0 0 0 18 12 10 33 13 18 46 123
2022/20231.191 121 100 102 172 148 285 27 67 127 13 21 8
2023/2024464 18 53 55 49 42 122 6 15 7 15 40 42
2024/20251.280 57 117 40 218 88 13 37 37 167 91 106 309
2025/20263.496 263 156 259 620 895 239 315 180 250 174 48 97
2026/20271.074 68 97 226 603 80 0 0 0 0 0 0 0
Totale 11.256